Challenge
Despite strong global evidence supporting intensive cholesterol management for secondary cardiovascular prevention, adoption across parts of Asia remained inconsistent.
Clinical hesitancy surrounding long-term use of high-intensity statin therapy persisted due to perceived tolerability and safety concerns in Asian patient populations, contributing to variation in treatment practices and suboptimal risk reduction.
Approach
A multi-country evidence generation and scientific engagement strategy was developed to address regional practice barriers using locally relevant data and expert leadership.
Key initiatives included:
Identifying and aligning leading cardiovascular experts across Asia around a unified evidence-generation strategy focused on regional clinical needs.
Establishing a pragmatic approach to real-world evidence development using large-scale healthcare database resources capable of generating meaningful population-level insights.
Supporting collaborative analysis, publication, and dissemination of regionally relevant outcomes data in partnership with academic investigators.
Enabling expert-led scientific education and peer-to-peer engagement to translate emerging evidence into clinical practice discussions across multiple countries.
Outcome
The initiative contributed to:
Increased regional confidence in evidence-based cholesterol management strategies for secondary cardiovascular prevention.
Broader adoption of intensive lipid-lowering approaches in clinical practice discussions and treatment recommendations.
Strengthened collaboration between academic leaders and healthcare stakeholders across multiple Asian markets.
Greater recognition of the importance of locally generated real-world evidence in informing regional healthcare decisions.
Key Insight
Combining locally relevant evidence generation with coordinated expert engagement can accelerate changes in clinical practice and improve adoption of evidence-based care.